cetrelimab
Showing 1 - 9 of 9
NSCLC Trial in Korea, Republic of, Malaysia, United States (Cetrelimab, Amivantamab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Cetrelimab
- Amivantamab
-
Fairfax, Virginia
- +3 more
Jun 16, 2023
Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)
Recruiting
- Carcinoma, Non-small-Cell Lung
- JNJ-86974680
- +2 more
-
New York, New York
- +1 more
Nov 8, 2023
Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)
Not yet recruiting
- Metastatic Castration-resistant Prostate Neoplasms
- JNJ-78278343
- Cetrelimab
-
Sarasota, Florida
- +7 more
Apr 6, 2023
Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)
Recruiting
- Small Cell Neuroendocrine Carcinoma
- +2 more
- Apalutamide
- Cetrelimab
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 21, 2022
Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston
Recruiting
- Aggressive Variant Prostate Carcinoma
- +5 more
- Cabazitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 10, 2022
Hepatitis B, Chronic Trial in Worldwide (Cetrelimab, Placebo)
Recruiting
- Hepatitis B, Chronic
- Cetrelimab
- Placebo
-
Edegem, Belgium
- +13 more
Jul 5, 2022